| CANCER & TREATMENTS SUPPORT & SURVIVORSHIP PREVENTION & RISK ASSESSMENT CLINICAL TRIALS & RESEARCH LIVING WITH CANCER | ||
Cancer Center in the NewsNov. 18 -- Drs. Katz, Hawley in NCI Cancer Bulletin A feature story in this week's Cancer Bulletin from the National Cancer Institute explores in-depth the work from Dr. Steven Katz and Dr. Sarah Hawley, from the Cancer Surveillance and Outcomes Research Team. The article highlights recent studies from the group that looked at why women with breast cancer choose mastectomy over breast-conserving surgery, including the role surgeons play in the patient's decision-making process. Oct. 26 - Dr. Junck on CNBC Larry Junck, M.D., Cancer Center/Neurology, appeared live on CNBC
to discuss the risk of brain tumors linked to cell phones. Dr. Junck
points out that there is little scientific evidence suggesting a
link and that there are far greater health hazards to worry about. Oct. 24 - Drs. Katz, Griggs on CNN.com Steven Katz, M.D., M.P.H., Socio-Behavioral/Breast Oncology, and
Jennifer Griggs, M.D., M.P.H., Socio-Behavorial/Breast Oncology,
are both quoted in a story that appeared on CNN.com.
The story talks about patient decision-making in breast cancer.
Both doctors stress why it's important for patients to take their
time in making their treatment decision. Oct. 7 - Dr. Merajver featured in JNCI A news article in the current issue of the Journal of the National Cancer Institute on inflammatory breast cancer prominently features Sofia Merajver, M.D., Ph.D., Breast Oncology. Dr. Merajver discusses the challenges that inflammatory breast cancer researchers have faced and the progress that has been made in this disease. An extract of the article is available for free. Oct. 4 - Dr. Pierce quoted in WebMD Lori Pierce, M.D., Breast Oncology, was quoted in WebMD about mammography findings revealing the future of breast cancer survival rates. The findings remind us that mammography is one of the most powerful tools we have, Dr. Pierce said. Oct. 5 - Dr. Chinnaiyan makes Crains 40 Under 40 Arul M. Chinnaiyan, M.D., Ph.D., Michigan Center for Translational Pathology, was selected by Crains Detroit Business as one of its 40 Under 40, a program that honors those who have made their mark before hitting the age of 40. Dr. Chinnaiyan was chosen due to his research of gene fusion and efforts to produce a commercial product, including co-founding two Michigan-based companies. Carrying his picture and profile is Crains Detroit Business. Oct. 3 - Dr. Blayney on CNN Douglas W. Blayney, M.D., Internal Medicine, appeared on CNN to discuss health care reformation and how it will affect cancer care. According to Dr. Blayney, the reform that is produced needs to consider lifetime caps, preexisting conditions, and the ability to care for the many more cancer survivors [they] have in addition to prevention screenings. As cancer doctors, Blayney told the CNN correspondent, we want cancer to go away. See the interview at CNN.
|
University of Michigan Comprehensive Cancer Center © 2009 Regents of the University of Michigan / Developed & maintained by: Public Relations & Marketing Communications. Contact Us or UMHS. The information presented is not a tool for self diagnosis or a substitute for professional care. |
||||